Abstract
Purpose of Review
To establish the actual role of CT in the growing field of transcatheter valve interventions (THV).
Recent Findings
The development of empirical CT measurements, which are linked with outcomes.
Summary
CT is a reliable technique for assessing risk and planning transcatheter valve interventions for mitral and aortic valves. Pulmonic and tricuspid valve assessment with CT imaging is still in the early stages but there is room for development.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: •• Of major importance
Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364(23):2187–98. https://doi.org/10.1056/NEJMoa1103510.
Leon MB, Smith CR, Mack MJ, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016;374(17):1609–20. https://doi.org/10.1056/NEJMoa1514616.
Mack MJ, Leon MB, Thourani VH, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med. 2019;380(18):1695–705. https://doi.org/10.1056/NEJMoa1814052.
Popma JJ, Deeb GM, Yakubov SJ, et al. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med. 2019;380(18):1706–15. https://doi.org/10.1056/NEJMoa1816885.
Blanke P, Schoepf UJ, Leipsic JA. CT in transcatheter aortic valve replacement. Radiology. 2013;269(3):650–69. https://doi.org/10.1148/radiol.13120696.
•• Blanke P, Weir-McCall JR, Achenbach S, et al. Computed tomography imaging in the context of transcatheter aortic valve implantation (TAVI)/transcatheter aortic valve replacement (TAVR): an expert consensus document of the Society of Cardiovascular Computed Tomography. JACC Cardiovasc Imaging. 2019;12(1):1–24. https://doi.org/10.1016/j.jcmg.2018.12.003. This is a complete review over the most important findings about aortic valve transcatheter intervention.
•• Ribeiro HB, Rodés-Cabau J, Blanke P, et al. Incidence, predictors, and clinical outcomes of coronary obstruction following transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: insights from the VIVID registry. Eur Heart J. 2018;39(8):687–95. https://doi.org/10.1093/eurheartj/ehx455. Findings from this study show how the assessing of VTC linear measurement in aViV procedures is linked with outcomes, allowing to better patient selection.
Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet. 2006;368:1005–11.
Blanke P, Naoum C, Dvir D, et al. Predicting LVOT obstruction in transcatheter mitral valve implantation: concept of the neo-LVOT. JACC Cardiovasc Imaging. 2017;10(4):482–5. https://doi.org/10.1016/j.jcmg.2016.01.005.
•• Yoon SH, Bleiziffer S, Latib A, et al. Predictors of left ventricular outflow tract obstruction after transcatheter mitral valve replacement. JACC Cardiovasc Interv. 2019;12:182–93. Findings from this study show how the measurements of the neo LVOT area allow to make selection of patients for mitral procedures.
Yoon SH, Whisenant BK, Bleiziffer S, et al. Outcomes of transcatheter mitral valve replacement for degenerated bioprostheses, failed annuloplasty rings, and mitral annular calcification. Eur Heart J. 2019;40:441–51.
Guerrero M, Urena M, Himbert D, et al. 1-Year outcomes of transcatheter mitral valve replacement in patients with severe mitral annular calcification. J Am Coll Cardiol. 2018;71:1841–53.
Khan JM, Babaliaros VC, Greenbaum AB, et al. Anterior leaflet laceration to prevent ventricular outflow tract obstruction during transcatheter mitral valve replacement. J Am Coll Cardiol. 2019;73(20):2521–34. https://doi.org/10.1016/j.jacc.2019.02.076.
Russell HM, Guerrero ME, Salinger MH, et al. Open atrial transcatheter mitral valve replacement in patients with mitral annular calcification. J Am Coll Cardiol. 2018. https://doi.org/10.1016/j.jacc.2018.07.033.
Lisko JC, Gleason P, Yousef A, Clements S, Babaliaros V, Lerakis S. Use of alcohol septal ablation to treat iatrogenic left ventricular outflow tract obstruction during transcatheter mitral valve replacement. J Am Coll Cardiol. 2018;71(11):A2210. https://doi.org/10.1016/s0735-1097(18)32751-7.
De Vecchi A, Marlevi D, Nordsletten DA, Ntalas I, Leipsic J, Bapat V, et al. Left ventricular outflow obstruction predicts increase in systolic pressure gradients and blood residence time after transcatheter mitral valve replacement. Sci Rep. 2018;8:15540–11. https://doi.org/10.1038/s41598-018-33836-7.
Sorajja P, Moat N, Badhwar V, et al. Initial feasibility study of a new transcatheter mitral prosthesis: the first 100 patients. J Am Coll Cardiol. 2019;73:1250–60.
Taramasso M, Vanermen H, Maisano F, Guidotti A, La Canna G, Alfieri O. The growing clinical importance of secondary tricuspid regurgitation. J Am Coll Cardiol. 2012;59:703–10.
Kilic A, Saha-Chaudhuri P, Rankin JS, Conte JV. Trends and outcomes of tricuspid valve surgery in North America: an analysis of more than 50,000 patients from the Society of Thoracic Surgeons database. Ann Thorac Surg. 2013;96:1546–52.
Spinner EM, Buice D, Yap CH, Yoganathan AP. The effects of a three-dimensional, saddle-shaped annulus on anterior and posterior leaflet stretch and regurgitation of the tricuspid valve. Ann Biomed Eng. 2012;40(5):996–1005. https://doi.org/10.1007/s10439-011-0471-6.
Praz F, Khalique OK, Dos Reis Macedo LG, Pulerwitz TC, Jantz J, Wu IY, et al. Comparison between three-dimensional echocardiography and computed tomography for comprehensive tricuspid annulus and valve assessment in severe tricuspid regurgitation: implications for tricuspid regurgitation grading and transcatheter therapies. J Am Soc Echocardiogr. 2018;31:1190–202.
Colli A, et al. Transcatheter tricuspid valve replacement with a self-expanding bioprosthesis. J Thorac Cardiovasc Surg. 156(3):1064–6 Shahanavaz S, McElhinney DB.
Taramasso M, Alessandrini H, Latib A, et al. Outcomes after current transcatheter tricuspid valve intervention: mid-term results from the international TriValve registry. JACC Cardiovasc Interv. 2019. https://doi.org/10.1016/j.jcin.2018.10.022.
Babaliaros VC, Hijazi ZM, Fahey JT, et al. 3-year outcomes of the Edwards SAPIEN transcatheter heart valve for conduit failure in the pulmonary position from the COMPASSION multicenter clinical trial. JACC Cardiovasc Interv. 2018;11(19):1920–9. https://doi.org/10.1016/j.jcin.2018.06.001.
Le Gloan L, Plessis J, Tahhan N, et al. Edwards SAPIEN transcatheter pulmonary valve implantation. JACC Cardiovasc Interv. 2018;11(19):1909–16. https://doi.org/10.1016/j.jcin.2018.05.050.
Nordmeyer J, Ewert P, et al. Acute and midterm outcomes of the post-approval MELODY Registry: a multicentre registry of transcatheter pulmonary valve implantation. Eur Heart J. 2019;12:1–10. https://doi.org/10.1093/eurheartj/ehz201.
Bonhoeffer P, Boudjemline Y, Saliba Z, et al. Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction. Lancet. 2000;356(9239):1403–5.
Sinha S, Aboulhosn J, Levi DS. Transcatheter pulmonary valve replacement in congenital heart disease. Interv Cardiol Clin. 2019;8(1):59–71. https://doi.org/10.1016/j.iccl.2018.08.006.
Gales J, Krasuski RA, Fleming GA. Transcatheter valve replacement for right-sided valve disease in congenital heart patients. Prog Cardiovasc Dis. 2018;61(3–4):347–59. https://doi.org/10.1016/j.pcad.2018.09.003.
Driesen BW, Warmerdam EG, Sieswerda G-JT, et al. Percutaneous pulmonary valve implantation; current status and future perspectives. Curr Cardiol Rev. 2019;15:1–12.
Shahanavaz S, McElhinney DB. Transcatheter pulmonary valve replacement: evolving indications and application. Futur Cardiol. 2018;14(6):511–24. https://doi.org/10.2217/fca-2018-0065.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Marcelo Godoy, Ahmed Mugharbil, and Malcom Anastasius declare that they have no conflict of interest.
Jonathon Leipsic reports receiving institutional support from Edwards, Medtronic, and Abbott. He is also a consultant for Circle CVI and Heartflow.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Valvular Heart Disease
Rights and permissions
About this article
Cite this article
Godoy, M., Mugharbil, A., Anastasius, M. et al. Cardiac Computed Tomography (CT) Evaluation of Valvular Heart Disease in Transcatheter Interventions. Curr Cardiol Rep 21, 154 (2019). https://doi.org/10.1007/s11886-019-1241-6
Published:
DOI: https://doi.org/10.1007/s11886-019-1241-6